Back to Search Start Over

T-cell and antibody responses to phospholipase A2 from different species show distinct cross-reactivity patterns.

Authors :
Sin, B. A.
Akdis, M.
Zumkehr, J.
Bezzine, S.
Bekpen, C.
Lambeau, G.
Akdis, C. A.
Source :
Allergy; Dec2011, Vol. 66 Issue 12, p1513-1521, 9p, 2 Diagrams, 4 Graphs
Publication Year :
2011

Abstract

To cite this article: Sin BA, Akdis M, Zumkehr J, Bezzine S, Bekpen C, Lambeau G, Akdis CA. T-cell and antibody responses to phospholipase A<subscript>2</subscript> from different species show distinct cross-reactivity patterns. Allergy 2011; 66: 1513-1521. Abstract Background: Secreted phospholipases A<subscript>2</subscript> (sPLA<subscript>2</subscript>) represent antigens to which humans may be rarely or frequently exposed. Thus, the investigation of humoral and cellular immune responses to sPLA<subscript>2</subscript>s from different species can provide a suitable model in the study of antibody and T-cell cross-reactivity. Methods: Specific IgE, IgG<subscript>1</subscript>, IgG<subscript>4</subscript>, and IgA antibodies were analyzed by ELISA against sPLA<subscript>2</subscript>s from pancreas of Bos taurus (BT), Apis mellifera (AM) bee venom, Daboia russellii (DR) and Naja mossambica (NM) snake venoms, and human group III (hGIII) sPLA<subscript>2</subscript> using sera of nonallergic beekeepers, AM-allergic patients, and healthy controls. T-cell cross-reactivity was investigated in PBMC, and T-cell clones (TCC) are generated against AM sPLA<subscript>2</subscript>. Results: Hyperimmune and allergic individuals showed high levels of sPLA<subscript>2</subscript>-specific IgG<subscript>4</subscript> and significant IgG<subscript>4</subscript> cross-reactivity between BT, DR, and NM sPLA<subscript>2</subscript>s. Furthermore, IgE, IgA, and IgG<subscript>1</subscript> cross-reactivities against BT, DR, and NM sPLA<subscript>2</subscript>s were also detectable in the range of 22.2-44.8%. Allergic patients showed significant T-cell proliferative response to NM sPLA<subscript>2</subscript> together with increased IFN-γ and IL-13 production even though they had never been exposed to cobra venom. Although nonallergic healthy controls show no cross-reactivity at T-cell level, they did have low levels of IgG<subscript>4</subscript> and IgA against BT, DR, and NM sPLA<subscript>2</subscript>s. Human TCC spanning three major T-cell epitopes of AM sPLA<subscript>2</subscript> showed minor proliferative response to NM and hGIII sPLA<subscript>2</subscript>s. Conclusions: This study shows that T cells and antibodies may show cross-reactivity between different species without being naturally exposed to sPLA<subscript>2</subscript>s. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01054538
Volume :
66
Issue :
12
Database :
Complementary Index
Journal :
Allergy
Publication Type :
Academic Journal
Accession number :
70250227
Full Text :
https://doi.org/10.1111/j.1398-9995.2011.02689.x